JHS SVENDGAARD LABORATORIES
|
JHS SVENDGAARD LABORATORIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -2.31 | -0.52 | -2.20 | -0.62 | 0.19 |
| CEPS(Rs) | -1.38 | 0.29 | -1.47 | 0.43 | 1.33 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 19.88 | 21.67 | 22.16 | 28.60 | 27.56 |
| Tax Rate(%) | -57.86 | -18.35 | 23.66 | 4,264.47 | -38.71 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -4.36 | -1.32 | -10.70 | -0.98 | 1.90 |
| EBIT Margin(%) | -12.98 | -4.19 | -26.41 | 1.74 | 2.19 |
| Pre Tax Margin(%) | -13.60 | -4.84 | -27.05 | 0.12 | 0.96 |
| PAT Margin (%) | -21.46 | -5.73 | -20.65 | -4.97 | 1.33 |
| Cash Profit Margin (%) | -12.82 | 3.23 | -13.56 | 3.20 | 8.52 |
| Performance Ratios | |||||
| ROA(%) | -10.27 | -2.01 | -8.11 | -1.98 | 0.60 |
| ROE(%) | -11.61 | -2.36 | -9.75 | -2.36 | 0.76 |
| ROCE(%) | -6.80 | -1.71 | -12.43 | 0.82 | 1.24 |
| Asset Turnover(x) | 0.48 | 0.35 | 0.39 | 0.40 | 0.45 |
| Sales/Fixed Asset(x) | 0.69 | 0.60 | 0.88 | 0.96 | 1.16 |
| Working Capital/Sales(x) | 3.16 | 3.48 | 1.76 | 1.44 | 1.03 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.45 | 1.66 | 1.14 | 1.04 | 0.87 |
| Receivable days | 51.46 | 80.98 | 78.87 | 162.56 | 280.04 |
| Inventory Days | 48.67 | 66.11 | 54.01 | 50.23 | 31.19 |
| Payable days | 143.68 | 237.71 | 166.85 | 139.67 | 208.84 |
| Valuation Parameters | |||||
| PER(x) | - | - | - | - | 107.20 |
| PCE(x) | -8.11 | 56.16 | -10.71 | 48.27 | 14.94 |
| Price/Book(x) | 0.56 | 0.76 | 0.71 | 0.72 | 0.72 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.88 | 1.72 | 1.00 | 1.48 | 1.07 |
| EV/Core EBITDA(x) | -71.69 | 36.03 | 37.75 | 14.93 | 11.43 |
| EV/EBIT(x) | -6.80 | -41.00 | -3.79 | 85.26 | 49.00 |
| EV/CE(x) | 0.46 | 0.70 | 0.49 | 0.68 | 0.61 |
| M Cap / Sales | 1.04 | 1.81 | 1.45 | 1.55 | 1.28 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 29.94 | -16.53 | -1.67 | -14.40 | -27.57 |
| Core EBITDA Growth(%) | -133.54 | 50.21 | -73.70 | -9.66 | -38.98 |
| EBIT Growth(%) | -302.38 | 86.75 | -1,596.63 | -32.21 | 156.75 |
| PAT Growth(%) | -386.59 | 76.84 | -308.38 | -419.53 | 127.65 |
| EPS Growth(%) | -345.63 | 76.52 | -253.05 | -435.46 | 157.26 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.03 | 0.02 | - | - | - |
| Current Ratio(x) | 2.18 | 1.87 | 2.31 | 4.18 | 5.23 |
| Quick Ratio(x) | 1.70 | 1.33 | 1.96 | 3.54 | 4.73 |
| Interest Cover(x) | -21.13 | -6.44 | -40.98 | 1.07 | 1.78 |
| Total Debt/Mcap(x) | 0.05 | 0.03 | - | 0.01 | 0.01 |
Compare Financial Ratios of peers of JHS SVENDGAARD LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JHS SVENDGAARD LABORATORIES | ₹104.8 Cr | -4.4% | 10.2% | -46.5% | Stock Analytics | |
| HINDUSTAN UNILEVER | ₹574,722.0 Cr | -1.8% | -3.9% | -3.7% | Stock Analytics | |
| GODREJ CONSUMER PRODUCTS | ₹119,145.0 Cr | 5.3% | 1.3% | -9.3% | Stock Analytics | |
| DABUR INDIA | ₹91,699.8 Cr | 1.8% | 4.2% | -8% | Stock Analytics | |
| COLGATEPALMOLIVE (INDIA) | ₹59,577.1 Cr | -3.4% | -1.1% | -28.8% | Stock Analytics | |
| PROCTER & GAMBLE HYGIENE AND HEALTH CARE | ₹43,530.5 Cr | -0.3% | -6.1% | -17.5% | Stock Analytics | |
JHS SVENDGAARD LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JHS SVENDGAARD LABORATORIES | -4.4% |
10.2% |
-46.5% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses
